Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy

Mark N. Cruickshank, Alicia Oshlack, Christiane Theda, Peter G. Davis, David Martino, Penelope Sheehan, Yun Dai, Richard Saffery, Lex W. Doyle, Jeffrey M. Craig

Research output: Contribution to journalArticle

Abstract

Background: Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort to measure the epigenetic mark of DNA methylation at birth and 18 years comparing survivors of extremely preterm birth with infants born at term. Methods: Using 12 extreme preterm birth cases and 12 matched, term controls, we extracted DNA from archived neonatal blood spots and blood collected in a similar way at 18 years of age. DNA methylation was measured at 347,789 autosomal locations throughout the genome using Infinium HM450 arrays. Representative methylation differences were confirmed by Sequenom MassArray EpiTYPER. Results: At birth we found 1,555 sites with significant differences in methylation between term and preterm babies. At 18 years of age, these differences had largely resolved, suggesting that DNA methylation differences at birth are mainly driven by factors relating to gestational age, such as cell composition and/or maturity. Using matched longitudinal samples, we found evidence for an epigenetic legacy associated with preterm birth, identifying persistent methylation differences at ten genomic loci. Longitudinal comparisons of DNA methylation at birth and 18 years uncovered a significant overlap between sites that were differentially-methylated at birth and those that changed with age. However, we note that overlapping sites may either differ in the same (300/1,555) or opposite (431/1,555) direction during gestation and aging respectively. Conclusions: We present evidence for widespread methylation differences between extreme preterm and term infants at birth that are largely resolved by 18 years of age. These results are consistent with methylation changes associated with blood cell development, cellular composition, immune induction and age at these time points. Finally, we identified ten probes significantly associated with preterm individuals and with greater than 5% methylation discordance at birth and 18 years that may reflect a long term epigenetic legacy of preterm birth.

Original languageEnglish (US)
Article number96
JournalGenome Medicine
Volume5
Issue number10
DOIs
StatePublished - Oct 18 2013
Externally publishedYes

Fingerprint

Premature Birth
Epigenomics
Gestational Age
Parturition
Methylation
DNA Methylation
Premature Infants
Blood Cells
Genome
Pregnancy
DNA
Health

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Molecular Biology
  • Molecular Medicine

Cite this

Cruickshank, M. N., Oshlack, A., Theda, C., Davis, P. G., Martino, D., Sheehan, P., ... Craig, J. M. (2013). Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy. Genome Medicine, 5(10), [96]. https://doi.org/10.1186/gm500

Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy. / Cruickshank, Mark N.; Oshlack, Alicia; Theda, Christiane; Davis, Peter G.; Martino, David; Sheehan, Penelope; Dai, Yun; Saffery, Richard; Doyle, Lex W.; Craig, Jeffrey M.

In: Genome Medicine, Vol. 5, No. 10, 96, 18.10.2013.

Research output: Contribution to journalArticle

Cruickshank, MN, Oshlack, A, Theda, C, Davis, PG, Martino, D, Sheehan, P, Dai, Y, Saffery, R, Doyle, LW & Craig, JM 2013, 'Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy', Genome Medicine, vol. 5, no. 10, 96. https://doi.org/10.1186/gm500
Cruickshank, Mark N. ; Oshlack, Alicia ; Theda, Christiane ; Davis, Peter G. ; Martino, David ; Sheehan, Penelope ; Dai, Yun ; Saffery, Richard ; Doyle, Lex W. ; Craig, Jeffrey M. / Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy. In: Genome Medicine. 2013 ; Vol. 5, No. 10.
@article{1c6cefdf9a974730930e519218233f24,
title = "Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy",
abstract = "Background: Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort to measure the epigenetic mark of DNA methylation at birth and 18 years comparing survivors of extremely preterm birth with infants born at term. Methods: Using 12 extreme preterm birth cases and 12 matched, term controls, we extracted DNA from archived neonatal blood spots and blood collected in a similar way at 18 years of age. DNA methylation was measured at 347,789 autosomal locations throughout the genome using Infinium HM450 arrays. Representative methylation differences were confirmed by Sequenom MassArray EpiTYPER. Results: At birth we found 1,555 sites with significant differences in methylation between term and preterm babies. At 18 years of age, these differences had largely resolved, suggesting that DNA methylation differences at birth are mainly driven by factors relating to gestational age, such as cell composition and/or maturity. Using matched longitudinal samples, we found evidence for an epigenetic legacy associated with preterm birth, identifying persistent methylation differences at ten genomic loci. Longitudinal comparisons of DNA methylation at birth and 18 years uncovered a significant overlap between sites that were differentially-methylated at birth and those that changed with age. However, we note that overlapping sites may either differ in the same (300/1,555) or opposite (431/1,555) direction during gestation and aging respectively. Conclusions: We present evidence for widespread methylation differences between extreme preterm and term infants at birth that are largely resolved by 18 years of age. These results are consistent with methylation changes associated with blood cell development, cellular composition, immune induction and age at these time points. Finally, we identified ten probes significantly associated with preterm individuals and with greater than 5{\%} methylation discordance at birth and 18 years that may reflect a long term epigenetic legacy of preterm birth.",
author = "Cruickshank, {Mark N.} and Alicia Oshlack and Christiane Theda and Davis, {Peter G.} and David Martino and Penelope Sheehan and Yun Dai and Richard Saffery and Doyle, {Lex W.} and Craig, {Jeffrey M.}",
year = "2013",
month = "10",
day = "18",
doi = "10.1186/gm500",
language = "English (US)",
volume = "5",
journal = "Genome Medicine",
issn = "1756-994X",
publisher = "BioMed Central",
number = "10",

}

TY - JOUR

T1 - Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy

AU - Cruickshank, Mark N.

AU - Oshlack, Alicia

AU - Theda, Christiane

AU - Davis, Peter G.

AU - Martino, David

AU - Sheehan, Penelope

AU - Dai, Yun

AU - Saffery, Richard

AU - Doyle, Lex W.

AU - Craig, Jeffrey M.

PY - 2013/10/18

Y1 - 2013/10/18

N2 - Background: Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort to measure the epigenetic mark of DNA methylation at birth and 18 years comparing survivors of extremely preterm birth with infants born at term. Methods: Using 12 extreme preterm birth cases and 12 matched, term controls, we extracted DNA from archived neonatal blood spots and blood collected in a similar way at 18 years of age. DNA methylation was measured at 347,789 autosomal locations throughout the genome using Infinium HM450 arrays. Representative methylation differences were confirmed by Sequenom MassArray EpiTYPER. Results: At birth we found 1,555 sites with significant differences in methylation between term and preterm babies. At 18 years of age, these differences had largely resolved, suggesting that DNA methylation differences at birth are mainly driven by factors relating to gestational age, such as cell composition and/or maturity. Using matched longitudinal samples, we found evidence for an epigenetic legacy associated with preterm birth, identifying persistent methylation differences at ten genomic loci. Longitudinal comparisons of DNA methylation at birth and 18 years uncovered a significant overlap between sites that were differentially-methylated at birth and those that changed with age. However, we note that overlapping sites may either differ in the same (300/1,555) or opposite (431/1,555) direction during gestation and aging respectively. Conclusions: We present evidence for widespread methylation differences between extreme preterm and term infants at birth that are largely resolved by 18 years of age. These results are consistent with methylation changes associated with blood cell development, cellular composition, immune induction and age at these time points. Finally, we identified ten probes significantly associated with preterm individuals and with greater than 5% methylation discordance at birth and 18 years that may reflect a long term epigenetic legacy of preterm birth.

AB - Background: Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort to measure the epigenetic mark of DNA methylation at birth and 18 years comparing survivors of extremely preterm birth with infants born at term. Methods: Using 12 extreme preterm birth cases and 12 matched, term controls, we extracted DNA from archived neonatal blood spots and blood collected in a similar way at 18 years of age. DNA methylation was measured at 347,789 autosomal locations throughout the genome using Infinium HM450 arrays. Representative methylation differences were confirmed by Sequenom MassArray EpiTYPER. Results: At birth we found 1,555 sites with significant differences in methylation between term and preterm babies. At 18 years of age, these differences had largely resolved, suggesting that DNA methylation differences at birth are mainly driven by factors relating to gestational age, such as cell composition and/or maturity. Using matched longitudinal samples, we found evidence for an epigenetic legacy associated with preterm birth, identifying persistent methylation differences at ten genomic loci. Longitudinal comparisons of DNA methylation at birth and 18 years uncovered a significant overlap between sites that were differentially-methylated at birth and those that changed with age. However, we note that overlapping sites may either differ in the same (300/1,555) or opposite (431/1,555) direction during gestation and aging respectively. Conclusions: We present evidence for widespread methylation differences between extreme preterm and term infants at birth that are largely resolved by 18 years of age. These results are consistent with methylation changes associated with blood cell development, cellular composition, immune induction and age at these time points. Finally, we identified ten probes significantly associated with preterm individuals and with greater than 5% methylation discordance at birth and 18 years that may reflect a long term epigenetic legacy of preterm birth.

UR - http://www.scopus.com/inward/record.url?scp=84885501009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885501009&partnerID=8YFLogxK

U2 - 10.1186/gm500

DO - 10.1186/gm500

M3 - Article

C2 - 24134860

AN - SCOPUS:84885501009

VL - 5

JO - Genome Medicine

JF - Genome Medicine

SN - 1756-994X

IS - 10

M1 - 96

ER -